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Abstract 
Spirulina platensis (SP) is a filamentous cyanobacterium microalgae with potent dietary 
phyto-antioxidant, anti-inflammatory and anti-cancerous properties. The present study 
aimed to investigate the chemopreventive effect of SP against rat liver toxicity and carcino-
genesis induced by dibutyl nitrosamine (DBN) precursors, and further characterized its un-
derlying mechanisms of action in HepG2 cell line. Investigation by light and electron mi-
croscopy showed that DBN treatment induced severe liver injury and histopathological 
abnormalities, which were prevented by SP supplementation. The incidence of liver tumors 
was significantly reduced from 80 to 20% by SP. Immunohistochemical results indicated that 
both PCNA and p53 were highly expressed in the liver of DBN-treated rats, but were sig-
nificantly reduced by SP supplementation. Molecular analysis indicated that SP treatment in-
hibited cell proliferation, which was accompanied by increased p21 and decreased Rb ex-
pression levels at 48hrs post-treatment. In addition, SP increased Bax and decreased Bcl-2 
expression, indicating induction of apoptosis by 48hrs. This is the first report of the in vivo 
chemopreventive effect of SP against DBN-induced rat liver cytotoxicity and carcinogenesis, 
suggesting its potential use in chemoprevention of cancer. 
Key words: Spirulina platensis; Phyto-antioxidant; Liver toxicity; Hepatocellular carcinoma; Elec-
tron microscopy; p53 
Introduction 
Spirulina platensis (SP) is a cyanobacterium being 
used in many countries as nutritional supplement for 
human and animal consumption. SP has been labeled 
as a powerful food, rich in proteins, carbohydrates, 
polyunsaturated fatty acids, sterols and some more 
vital elements like calcium, iron, zinc, magnesium, 
manganese and selenium. It is a natural source of vi-
tamin B12, vitamin E, ascorbic acid, tocopherols and 
whole spectrum of natural mixed carotene and xan-
thophyll phytopigments (1-3). 
SP is well known for its anti-inflammatory and 
anti-cancerous properties. A hot water extract of SP 
has been orally administered to patients as an 
anti-cancer and anti-viral agent. SP is best known as 
an immune booster by stimulating natural killer (NK) 
cells and co-operative action of IL-12 and IL-18 for 
NK-mediated IFN gamma production (4). These 
SP-stimulated NK cells can fight illnesses other than 
cancer. SP hinders the growth of oral cancer. SP ex-
tract has been shown to inhibit tumor initiation in Int. J. Biol. Sci. 2009, 5 
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Syrian hamster cheek pouch mucosa painted with 
7,12-dimethylbenz[a]anthracene (5). Such an inhibi-
tory effect may be attributed to the repair of carcino-
gen-damaged DNA, and SP has been suggested as an 
efficient radical scavenger (6-9). Other studies have 
reported that the unique polysaccharides of SP en-
hance cell nucleus enzyme activity and potentiate the 
process of DNA repair (10, 11) 
Since SP has many therapeutic roles including 
anticancer properties, the present study is the first of 
the in vivo effects of SP on DBN-induced hepatotoxic-
ity and carcinogenesis in the rat liver and its possible 
underlying molecular mechanisms on cell prolifera-
tion and apoptosis using HepG2 human liver cancer 
cell line as a model. 
 
Materials and Methods 
Cells, compounds and chemicals. HepG2 hepa-
tocellular carcinoma cells kindly provided by Dr. 
Hollenbach (LSU Health Sciences Center, New Or-
leans) were cultured in DMEM with 4500 mg/l glu-
cose and supplemented with 10% fetal bovine serum 
and 1% penicillin and streptomycin (0.1 ml/well). 
Mesenchymal stem cells (MSCs) kindly provided by 
Dr. David Welsh (LSU Health Sciences Center, New 
Orleans) were cultured in MEM-Alpha (Cat # 12561, 
GIBCO, CA, USA) supplemented with 16.5% of Bo-
vine Serum Albumin (Cat# S-11550, Atlanta Biologi-
cals, GA, USA) and 1% L-Glutamine (GIBCO, Cat# 
25030, GIBCO, CA, USA). SP algae used in this work 
was cultured in our laboratory of algal technology at 
Mansoura University, under optimal conditions on 
Zarrouk medium as previously described (12). Algal 
mass was harvested every 3 weeks by continuous 
centrifuge, air dried and ground to powder form. 
Chemicals were supplied by Sigma Chemical Co. (St 
Louis, MO) unless otherwise stated. The dibutylni-
trosoamine solution (DBN) was prepared by mixing 
2000 ppm of sodium nitrite (NaNO2) with 1000 ppm 
of dibutylamine (DBA) in drinking water.  
Alamar Blue Cell proliferation assay.  HepG2 
cells were seeded in 96-well plates in appropriate 
medium and incubated at 37 ºC and 5% CO2. SP was 
applied at different concentrations, in triplicates, to 
the wells to achieve final concentrations ranging from 
0 to 800 µg/ml. The suppression of cell growth was 
determined using the Alamar Blue assay (Alamar 
Biosciences, Sacramento, CA) as previously reported 
(13). Briefly, the concentration of alamar blue added 
to the cells was in an amount equal to 1% of the total 
medium volume. The oxidized form of this dye, 
which is non-toxic, is converted to the reduced form 
by mitochondrial enzyme activity of the viable cells. 
The shift in fluorescence was measured at 600 nm 
with excitation wavelength at 570 nm in a Fluorome-
ter (LabSystems Fluoreskan-II), 4 hours after addition 
of the dye and the results expressed as percent of 
controls. This method provides an accurate measure 
of the number of cells metabolizing the dye to a re-
duced state and is a sensitive and accurate means of 
monitoring cell proliferation. In order to ascertain the 
specificity of observed effects the MSCs were used as 
an example of non-cancerous cell type. MSCs were 
treated with the highest dose of SP (800 µg/ml), and 
growth of cells was evaluated using the alamar blue 
assay as described above. 
Western blot analysis of molecular pathways 
affected by SP treatment. HepG2 cells were treated 
with increasing concentrations of SP ranging from 0 to 
800μg/ml. Western blot analysis was performed as 
previously described (14). Proteins were extracted 
with a lysis buffer and precipitated using RIPA buffer 
(Santa Cruz Biotechnology, CA, USA). Protein sam-
ples (60μg) were boiled for 5 min in an equal volume 
of reducing buffer (5mM Tris/HCl pH 7.4, 4% (w/v) 
SDS, 20% (v/v) glycerol, 10% (v/v) mercaptoethanol, 
0.2% (w/v) bromophenol blue), resolved on 12% 
polyacrylamide gels, electroblotted onto nitrocellu-
lose membranes. The antibodies used were mono-
clonal anti-Rb, p53, p21, CDK6, BAX, and Bcl-2 anti-
body. After probing with the appropriate secondary 
antibody, nitrocellulose membranes were developed 
using Supersignal horseradish peroxidase according 
to the manufacturer’s instructions (Pierce Thermo 
Scientific, IL, USA) on Gel Doc (BioRad, CA, USA). 
Equal loading of the protein samples was assessed by 
re-probing the membrane with a 1:2000 dilution of 
β-actin antibody. All antibodies were supplied by 
Santa Cruz Biotechnology, CA, USA except anti-Rb 
antibody was supplied by BD Pharmingen, CA, USA.  
Animal Studies. This study was approved by the 
local ethical committee. Healthy adult male albino 
rats (Rattus rattus; 120±5g) were housed and main-
tained on 12 hours light/dark cycle under a constant 
temperature of 25±1oC with free access to food and 
drinking water. Rats were acclimatized to laboratory 
conditions for one week prior to experiments.  Ani-
mals were randomly divided into four groups (n=10 
per group) and treated for a period of 12 months as 
follows: 1) Group 1 (Untreated control group): ani-
mals were fed on a standard diet and given water ad. 
libitum for 12 months; 2) Group 2 (SP-treated group): 
animals were fed on a standard diet mixed with 1% SP 
powder, and given water ad. libtium for 12 months; 3) 
Group 3 (DBN-treated group): were fed on the same 
standard diet and given DBN precursors in their 
drinking water as described above, for 6 months fol-Int. J. Biol. Sci. 2009, 5 
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lowed by normal drinking water ( next 6 months) 
until the termination of the experiment; and 4) Group 
4 (DBN + SP-treated group): In addition to 
DBN-treatment (similar to Group 3), these animals 
were fed on a standard diet mixed with 1% SP powder 
throughout the experimental period (12 months). 
Body weight of the animal was recorded every month, 
and at the end of the 12 months treatment, animals 
were sacrificed, liver tissues were collected, fixed in 
10% formalin and then paraffin embedded for histol-
ogy and for tumor examination. 
Histology and Immunohistochemistry (IHC). 
F o u r  µ m  s e c t i o n s  o f  p a r a f f i n - e m b e d d e d  l i v e r  t i s s u e  
were analyzed for expression of p53 and PCNA by 
immunohistochemistry as described previously (14). 
Tissue sections were incubated with primary anti-p53 
and anti-PCNA antibodies (Zymed Laboratories, 
USA). Incubation with appropriate secondary anti-
body was followed by direct diaminobenzidine 
staining and light counterstaining with hematoxylin. 
As a negative control, tissue sections were incubated 
with PBS replacing the primary antibody.  
Electron Microscopy. The liver tissue was fixed, 
for 2 hours, in 2.5% glutaraldehyde buffered in 0.1 M 
cacodylate buffer (pH 7.2) at 4oC and post fixed in 1% 
cold osmium tetraoxide in 0.1M cacodylate at pH 7.2, 
for 3 hours. Ultrathin sections were obtained from 
specimens embedded in Lowicryl K4M resin after 
dehydration through graded ethanol series, substitu-
tion and polymerization at –200C. Ultrathin sections 
were obtained using an Ultracut S microtome (Leica, 
Vienna, Austria). Sections were mounted on 400-mesh 
collodion-carbon-coated nickel grids and examined 
with a Joel Electron Microscope (JAPAN) operating at 
60 kV. 
Statistical analysis.  Data was presented as 
Mean ± S.E.M. of at least triplicates or replicates from 
three experiments and the data were analyzed statis-
tically using Newman–Keuls multiple comparison 
test and Student's t-test using GraphPad Prism 2.01. 
Differences with P <0.05 were considered significant. 
All the experiments have been performed thrice and 
have obtained consistent results. 
 
 
Results 
In vitro studies 
Effect of SP on Hep-G2 cell proliferation. Ala-
mar blue cell proliferation assay was used to examine 
the cytotoxic effect of increasing doses of SP on 
Hep-G2 cells. The cells in the control group, treated 
only with the vehicle, reduced the dye in a linear time 
dependent manner (Figure 1A) over a 24 hr period. 
However, increasing concentrations of SP treatment 
reduced the metabolism (fluorescence)/proliferation 
rate in time and dose-dependent manner (Figure 1A), 
suggesting an induction of apoptosis and inhibition of 
cell proliferation in HepG2. However, no effect of SP 
was observed in MSC control cells. Based on these 
results, the concentration of 200µg of SP extract was 
used to treat HepG2 cells, and further elucidate the 
molecular mechanisms of action of SP involved in the 
regulation of cell cycle and apoptosis. 
 
Effect of SP extract on cell cycle and apop-
tosis-related proteins. HepG2 cells were treated with 
200 μg/ml of SP extract. Protein lysates collected at 24 
and 48hrs post-treatment were analyzed by western 
blot to examine the effect of SP extract on the expres-
sion of proteins associated with cell cycle regulation 
(p53, p21Waf1/Cip1 and Rb) and apoptosis (p53, bcl-2 
and Bax). Expression of p53 increased in response to 
SP and was maximal by 24 hrs followed by an in-
crease of its direct downstream target, the cell cycle 
inhibitor, p21Waf1/Cip1 (Figure 1B). In contrast, the ex-
pression of Rb, which was increased by 24hrs, 
dropped significantly by 48hrs, suggesting cell cycle 
arrest and inhibition of cell proliferation by SP (Figure 
1B). Furthermore, 48hrs post-SP treatment, the 
proapoptotic Bax was upregulated and the antiapop-
totic bcl-2 downregulated leading to an increased 
Bax/bcl-2 ratio, indicating induction of apoptosis of 
HepG2 cells by SP (Figure 1B). 
 
In vivo studies 
The in vitro results described above suggest that 
SP inhibits growth and induces apoptosis of the 
hepatocellular carcinoma cell line HepG2. 
DBN-induced rat liver carcinogenesis model was used 
to test this observation in vivo.  
Changes in the body weight gain and tumor in-
cidence.  The body weight of each animal was re-
corded every month during the whole period of the 
experiment. While rats fed on SP containing diet had 
similar final body weight (Figure 2A) to controls, 
DBN-treated rats showed a significant reduction (p< 
0.01). In addition, there was an increasing percentage 
of change in the body weight gain of the animal with 
time in all the groups described in this study (Figure 
2B). However, DBN-treatment slowed significantly 
the change in the body weight gain as compared to 
other groups. SP supplementation with DBN over-
came the loss in body weight loss, suggesting a pro-
tective effect of SP in these animals.  Int. J. Biol. Sci. 2009, 5 
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Figure 1. Effects of spirulina (SP) on proliferation (A) of the human hepatocellular carcinoma cells, HepG2, and on the 
expression (B) of genes associated with cell cycle and apoptosis mechanisms. A) Alamar blue cell proliferation assay was 
used to assess the cytotoxic effect of increasing doses of SP (0-800 µg/ml) on HepG2 cells. As described in materials and 
methods, the dye was reduced over a period of time and the fluorescence intensity was measured as mean fluorescence 
value (MFV). The cells in the control group, treated only with the vehicle, reduced the dye in a linear time dependent manner 
over a 24 hr period. Increasing concentrations of SP treatment reduced the metabolism (fluorescence)/proliferation rate in 
time and dose-dependent manner. B) A representative western blot analysis of expression of genes associated with cell 
cycle (p53, p21
Waf1/Cip1, and Rb) and apoptosis (p53, Bax and Bcl-2) mechanisms after treatment of HepG2 with 200 µg/ml of 
SP for 24 and 48 hrs (C: untreated cells). Equal protein loading was confirmed by re-probing the membrane for β-actin 
expression.  
 
 
Figure 2. Spirulina prevents the in-
hibitory effect of DBN on the final 
body weight (A) and the percentage of 
body weight change (B). A) The final 
body weight of each animal by the end 
of the duration of the experimental 
period (12 months) is given as mean ± 
SE. DBN-treatment reduced the final 
body weight, but spirulina supple-
mentation partially reversed the de-
crease in the body weight induced by 
DBN (p< 0.01)*. (Spir: Spirulina). B) 
The body weight of each animal was 
recorded every month, mean values 
were calculated and the percentage of 
body weight change was determined.  
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The animals were also examined for 
DBN-induced tumors in the liver. While none of the 
rats from either control or SP groups developed liver 
tumors, 80% of the rats showed DBN-induced liver 
tumors (Table 1). However, SP treatment reduced 
liver tumor incidence to 20% in the DBN+SP group 
(Table 1). These results suggest that SP can prevent 
DBN-initiated tumor development in the rat liver. 
Table 1: Chemoprevention of Spirulina against liver tu-
morigenesis 
Groups (n=10)  % of animals with liver tumors   
Control    0%  
Spirulina   0%  
DBN   80%  
DBN+Spirulina   20%  
 
Histopathological analysis of the liver tissue. 
Animals were sacrificed, liver tissues were collected, 
fixed in 10% formalin and then paraffin embedded for 
histology. Light microscopic investigations revealed 
that control (Figure 3A) and SP-fed (Figure 3B) rats 
demonstrated normal polyhedral hepatocytes and the 
boundaries of the sinusoids showed a single layer of 
fenestrated endothelial cells and kupffer cells. How-
ever, the liver of rats treated with DBN showed 
damaged hepatocytes with manifestations of exten-
sive cytoplasmic vacuolization, hydropic degenera-
tion (oedema), and hyperchromatic nuclei (Figures 3C 
and 3D). SP-DBN treated rats (Figures 3E and 3F) 
demonstrated dilatation in blood sinusoids, slight 
vacuolization in the cytoplasm of the hepatocytes, few 
pyknotic nuclei and active kupffer cells in the liver. 
This data indicate a partial prevention of the effects of 
DBN by SP.  
 
 
Figure 3. Prevention of DBN-induced 
histopathological abnormalities in rat 
liver by spirulina supplementation. 
A-B: Liver sections of control (A) and 
spirulina-treated (B) rats showing 
normal histological appearance of the 
liver, including central vein (CV), blood 
sinusoids (BS), hepatic cells (HC), 
kupffer cell (KC) and centrally located 
nuclei (N). C-D: Section of rat liver 
treated with DBN precursors revealed 
considerable number of damaged HC 
that have lost their characteristic ap-
pearance, with manifestations of hy-
dropic degeneration (HD), appearance 
of pyknotic nuclei (PN), fatty infiltra-
tions (FD), inflammatory leukocyte 
infiltrations (Li) and activated KC. E-F: 
Liver section of the rat treated with 
DBN supplemented with spirulina 
demonstrated restoration of normal 
arrangement of hepatocytes, although 
dilatation in blood sinusoids (DBS) and 
cytoplasmic vacuoles (V) were ob-
served. (Scale bar = 75µm). 
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Ultrastructural analysis of the livers. In electron 
microscope preparations, the cell surface of the he-
patic cells from control group was smooth, with large 
spherical nucleus and nucleoli showing fi-
brilo-granular network structure. The cytoplasm 
showed a granular appearance. There were profuse 
amount of rough endoplasmic reticulum especially 
around the nuclear envelope and between the mito-
chondria. The hepatic sinusoids were thin-walled 
with discontinuous layer of endothelial and Kupffer 
cells. The endothelial cells were extremely thin with 
an electron-lucent cytoplasm. The Kupffer cells were 
macrophages lining the sinusoids, with the endothe-
lial cells (Figures 4A, 4B and 4C). In animals treated 
with SP, the hepatic cell surfaces showed lateral in-
terdigitations. The nuclei were found to contain a 
large amount of electron-lucent euchromatin, scat-
tered areas of heterochromatin, and distinct nucleolus 
(Figure 4D). The cytoplasm of the hepatic cells con-
tained a fairly large amount of rough and smooth 
endoplasmic reticulum with many rounded mito-
chondria (Figures 4D and 4E). The hepatic sinusoids 
were found to contain only one discontinuous layer of 
lining cells. The endothelial cells were extremely thin 
with an electron-lucent cytoplasm and contained dif-
ferent varieties of vacuoles (Figures 4F and 4G).  
 
 
 
 
Figure 4. Normal ultrastructural appearance of rat liver cells of rat fed on standard diet containing spirulina. A-C: Rep-
resentative electron micrograph of hepatocytes (A-B) and blood sinusoid cells (C) from control rat liver. D-G: Repre-
sentative electron micrographs of rat liver cells treated with SP exhibiting the normal appearance of hepatocyte (D) as well 
as adjacent hepatic cell borders (E-G). N, nucleus; M, mitochondria; RER, rough endoplasmic reticulum; PV, pinocytic 
vesicle; ZO), zonulae occludents belt; MA, maculae adherens; BC, bile canaliculus; EN, endothelial cell; KC, Kuppfer cell; Di, 
space of Disse; NU, nucleolus; MV, microvilli; ER, endoplasmic reticulum; RBC, red blood cells. Original magnification, x 
15,000. 
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However, in DBN treated rats, most tumor cells 
were poorly differentiated due to rapid multiplica-
tion, with characteristic large rounded nuclei and 
large nucleoli (Figures 5A and 5B). When rats treated 
with DBN supplemented with SP, remarkable 
changes were observed, with differentiation of the 
hepatic cells rather than multiplication. The nuclei of 
all the hepatic cells contained small masses of con-
densed heterochromatin distributed throughout the 
nucleus and the cells showed appearance of large 
number of mitochondria. The cytoplasmic vacuoles 
were sparse and the fat droplets disappeared (Figures 
5C and 5D). 
Expression levels of p53 and PCNA in the liver. 
The expression of the tumor suppressor gene p53 and 
the cell proliferation marker PCNA was examined by 
IHC in the rat liver of all the groups. While, the ex-
pression of both p53 and PCNA were not affected by 
SP supplementation, DBN treatment led to strong 
increase in p53- and PCNA-positive cells; these ex-
pression levels were significantly reduced by SP sup-
plementation (Figures 6A and 6B). The liver sections 
of control and SP-treated rats stained for PCNA 
showed few nuclear positive cells as seen in Figure 6 
C1 and C2. However, DBN-treatment increased dra-
matically both the intensity of the immunostaining as 
well as the number of PCNA-positive hepatocytes 
(Figure 6 C3), which were significantly reduced by SP 
supplementation (Figure 6 C4).  
 
 
 
Figure 5. Ultrastructural evidence of DBN-induced pathological abnormalities in rat liver cells and its prevention by 
spirulina supplementation. A-B: Representative electron micrograph of rat liver cells treated with DBN precursors showing 
nucleus (N) with marginated heterochromatin, large nucleolus (NU), condensed mitochondria (M), lipid droplets (LD), 
glycogen particles (G), vacuoles (V), very large bile canaliculi (BC) with few microvilli (MV) and rough (RER) and smooth 
(SER) endoplasmic reticulum (x 6,000). C-D: Electron micrograph of hepatic cells in rats treated with DBN precursors and 
spirulina showing the normal appearance of the nuclei (N), large number of mitochondria (M) and also mitochondria with 
balloony of its cristae, electrolucent cytosol and rough endoplasmic reticulum (RER) and bile canaliculus (BC) with de-
generative microvilli (MV). Original magnification, X 10,000. Int. J. Biol. Sci. 2009, 5 
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Figure 6. Inhibition of the expression of p53 and the cell proliferation marker PCNA by spirulina in DBN-induced rat liver 
injury. Graphical representation of expression of the percentage of p53 positive cells (A) and the proliferating cell nuclear 
antigen (PCNA) labeling index (B) in the livers of all the groups studied. Both the percentage of p53 and the PCNA labeling 
index were significantly higher in DBN-treated rats (***p< 0.001), which were significantly decreased in DBN+Spirulina 
treatment (**p< 0.001). p53% is a value expressed to denote the percentage number of positive p53 nuclear stained cells. 
PCNA labeling index is the percentage number of positive cells stained for PCNA in each study group. C) Immunohisto-
chemistry of PCNA in the liver section from all the groups studied. Few weakly stained nuclei were detected in the 
hepatocytes of normal control rats (C1). The liver sections of rats fed with spirulina also showed PCNA immunostaining 
similar to background (C2). Liver sections of rats treated with DBN showed prominent and distinctly stained nuclei in the 
hepatocytes (C3). The number of PCNA-stained nuclei was reduced when DBN-treated rats are supplemented with 
spirulina diet (C4). (Scale bar = 75µm).  
 
 
Discussion 
The present investigation is the first report of the 
in vivo chemopreventive effect of SP against liver car-
cinogenesis induced by DBN. SP inhibited the inci-
dence of liver carcinogenesis and prevented 
DBN-induced hepatotoxicity which was demon-
strated by light and electron microscopy. The expres-
sion levels of proliferating cell nuclear antigen 
(PCNA) and p53 were highly elevated in the liver of 
DBN-treated rats, but were significantly reduced by 
SP supplementation. Investigation into the molecular 
mechanisms of action of SP in the hepatocellular car-
cinoma cells HepG2 revealed that SP induced p53, 
which in turn upregulated the cell cycle inhibitor p21 
to inhibit cell proliferation. In addition, SP-induced 
p53 was followed by an increase of Bax and a decrease 
of Bcl-2 expression, coinciding with induction of 
apoptosis (data not shown).  
SP  has been traditionally  used for nutrition 
worldwide by people from Mexico, Africa and Asia. It 
is being widely studied for its possible antioxidant, 
antibacterial, and antiparasitic properties, and for 
several medical conditions such as allergies, ulcers, 
anemia, heavy-metal poisoning, and radiation poi-
soning (4, 17). SP or its extracts can prevent or inhibit 
cancer in humans and animals (1-3, 10, 11, 18-21). 
In the present study, SP alone did not cause any 
side effects or organ toxicity as previously described 
(1, 8, 22), but it was remarkably effective in reducing 
the incidence of liver tumors, suggesting its potential 
therapeutic effect in our model. Mathew et al. re-
ported a chemopreventive role of SP against oral 
cancer (19). It has been suggested that the ability of SP Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
385
to inhibit carcinogenesis is due to its anti-oxidant 
properties that protect tissues from cell damage (23). 
The potential hepatoprotective role of SP may be as-
sociated with its antioxidant constituents such as se-
lenium, chlorophyll, carotene, gamma-linolenic acids, 
tocopherol, phenolic compounds content and vitamin 
E and C working individually or in synergy (24-27). 
SP has been shown to be effective against free radical 
induced cellular transformation (6, 8). In addition, 
phycocyanin, the main pigment present in SP, can 
inhibit cytochrome P450 mediated reactions involved 
in the formation of reactive metabolites of the hepa-
totoxins (7). Mittal et al. showed that SP significantly 
reduced the hepatic cytochrome P-450 content and 
significantly induced the hepatic glutathione 
S-transferase activity (28).  
The liver of rats treated with DBN showed 
damaged hepatocytes with manifestations of exten-
sive cytoplasmic vacuolization, hydropic degenera-
tion (oedema) and hyperchromatic nuclei, which was 
partially resolved by SP. At ultrasctructural level, the 
cytoplasm of the hepatocytes in this study showed 
different sizes of vacuoles. The cytoplasmic vacuoli-
zation implies increased permeability of cell mem-
branes, leading to an increase in intracellular water 
(29). Also, the hepatic cytoplasm of rats administered 
with DBN precursors displayed increased number of 
mitochondria, ballooning of the mitochondrial cristae 
(30). The pathological effect of DBN in the liver 
mainly due to the degradation products, either the 
carbonium ion or the diazoalkane. These two reactive 
metabolites may react with some vital compounds of 
the liver, such as DNA or proteins, by alkylation (31). 
Moreover, the liver had been found to be the main site 
of nitrosamine metabolism that was mainly confined 
to the microsomal fraction in the cells (32). In vitro 
studies revealed that polysaccharides of SP enhanced 
cell nucleus enzyme activity and DNA repair mecha-
nisms, which are known to be closely associated with 
chemoprevention properties of natural products. The 
most striking feature in these rats was the appearance 
of a large number of mitochondria and ample RER 
around the nucleus. Rats treated with diethyl ni-
trosamine and protected with red ginseng, showed 
hepatocytes with normal nucleus, large number of 
mitochondria and well developed RER indicating 
liver regeneration; extensive RER reflected the activity 
of the cell to produce high amount of proteins needed 
for normal differentiation (33).  
In the present study, liver cells of both control 
and SP did not express p53 protein. The wild-type p53 
protein cannot be detected by conventional immuno-
histochemical technique due to its shorter half life and 
hence does not accumulate in tumor cells (34-36). 
However, liver sections of rats treated with DBN 
precursors showed significant increase in p53 protein, 
which was reduced by SP supplementation. This 
might be attributed to the anti-mutagenic effect of SP 
which minimized DNA damage caused by DBN 
precursors. Another plausible explanation is that SP 
might have prevented high levels of wild-type p53, 
produced in response to SP, from being transformed 
into mutant p53 (37). The wild-type p53 is a tumor 
suppressor gene involved in several different mecha-
nisms including gene transcription, DNA synthesis, 
and repair, and programmed cell death (38-42). Mu-
tation in and loss of the p53 gene are the most com-
mon genetic defects in human malignant tumors, in-
cluding hepatocellular carcinoma (HCC) (40, 43). 
Oxidative stress and chronic inflammation are closely 
associated with increased risk of cancer (44). High 
concentrations of nitric oxide (NO) products gener-
ated by DBN precursors can cause DNA damage, ei-
ther directly or through secondary molecules, by ni-
troso-active deamination, DNA strand breakage, and 
DNA modifications (45). NO-induced DNA damage 
can lead to p53 accumulation and p53-mediated 
apoptosis (46, 47). Moreover, the higher the rate of p53 
expression, the higher the degree of HCC malignancy 
(48). 
In addition to p53, PCNA is closely associated 
with cell cycle, and its expression increases at the end 
of G1 phase, reaches its maximum in S-phase, declines 
during G2 phase and is absent during the mitotic 
phase and in quiescent cells (42, 49, 50). In the present 
study, the liver of both control and SP-treated rats 
showed few PCNA-positive cells in the proliferating 
stage. In contrast, liver sections of DBN-treated rats 
showed significant increase in the number of 
PCNA-positive cells, which was significantly reduced 
by SP supplementation. Previous studies have dem-
onstrated that PCNA labeling index increased se-
quentially from normal tissue through premalignant 
stage to carcinoma of various tumors (51, 52). On the 
other hand, the bioactive pigment, C-PC 
(C-phycocyanin), and other proteins of SP had in-
hibitory activity on proliferation of cancer cells (10, 
53).  
Our  in vitro studies revealed an increase in 
Bax/Bcl-2 ratio, which was accompanied by induction 
of apoptosis as previously reported using C-PC in-
stead of the whole extract of SP (54, 55). These data 
suggest that C-PC is the main active ingredient of SP 
in inducing cancer cell death, and a potential 
anti-cancer agent. The decreased expression of the 
phoshoprotein, Rb, involved in regulating progres-
sion through the cell cycle and a concomitant increase 
in p21 expression indicate that these proteins along Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
386
with p53 are important for SP-driven inhibition of cell 
proliferation (56). This study is the first to report 
p53/p21/Rb and p53/bax/Bcl-2 as potential path-
ways regulating SP-induced cell cycle inhibition and 
apoptosis, respectively.  
In summary, our study is the first to show that 
DBN-induced severe liver injury and carcinogenesis 
in rat liver were prevented by SP supplementation, 
suggesting that SP is a protective phyto-antioxidant 
against liver toxicity and an anti-tumor agent. Further 
pre-clinical and clinical trials are warranted to char-
acterize the efficacy of SP in combination with exist-
ing therapeutics for chemoprevention and chemo-
therapy of hepatocellular carcinoma. 
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